original ) (raw )The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Claudio Benadiva
Fertility and Sterility, 2008
View PDFchevron_right
Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization–embryo transfer cycles
A. Yuzpe
Fertility and Sterility, 1999
View PDFchevron_right
Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support
Yuval Bdolah
Human Reproduction, 2012
View PDFchevron_right
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation
Raoul Orvieto
Journal of ovarian research, 2015
View PDFchevron_right
Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
John Nulsen
Fertility and Sterility, 2010
View PDFchevron_right
GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial
Jing-Yan Song
Frontiers in Endocrinology, 2022
View PDFchevron_right
Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist
Claudio Benadiva
Fertility and Sterility, 2011
View PDFchevron_right
Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates
Eleuterio Hernandez
Fertility and Sterility, 2006
View PDFchevron_right
A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG
Miltiades Kyprianou
Human Reproduction Open, 2020
View PDFchevron_right
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome
Walter Vegetti
Human Reproduction, 2005
View PDFchevron_right
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
Anne Zedeler
Human Reproduction, 2016
View PDFchevron_right
Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
ayten türkkanı
Gynecology Obstetrics and Reproductive Medicine, 2016
View PDFchevron_right
Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols
Roy Homburg
Reproductive BioMedicine Online, 2006
View PDFchevron_right
Outcomes Comparison of In-Vitro Fertilization (IVF) between GnRH Agonist Trigger and hCG for Final Oocyte Maturation
Andon Hestiantoro
KnE Medicine, 2016
View PDFchevron_right
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
Evangelos Papanikolaou , Michel Camus
Fertility and Sterility, 2006
View PDFchevron_right
Comparison of GNRH Agonist with Low-Dose Urinary HCG for the Induction of Final Oocyte Maturation in High-Risk Patients Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer (Icsi-Et)
Faiz Alwaeely
Basrah Journal of Surgery, 2013
View PDFchevron_right
Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome
murat sonmezer
Reproductive BioMedicine Online, 2017
View PDFchevron_right
Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels
Eleuterio Hernandez
Fertility and Sterility, 2010
View PDFchevron_right
Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial
Paulo Serafini , Joséroberto Alegretti
Fertility and Sterility, 2006
View PDFchevron_right
Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified `coasting' strategy based on ultrasound for identification of high-risk patients
sajid hussain
Human Reproduction, 2001
View PDFchevron_right
Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization
Martha Aguirre
Fertility and Sterility, 2008
View PDFchevron_right
A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy
Bruce Rose
Journal of Assisted Reproduction and Genetics, 2013
View PDFchevron_right
GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data
Ido Solt
Human Reproduction Update, 2012
View PDFchevron_right
Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
Erkan Erdem
Saudi Medical Journal
View PDFchevron_right
GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles. Systematic review & meta-analysis
Mohamed Ahmed
Journal of Advanced Research, 2015
View PDFchevron_right
Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality
Raoul Orvieto
Fertility and Sterility, 2009
View PDFchevron_right
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial
Juan Jacobo Zelaya Guillén
Human Reproduction, 2006
View PDFchevron_right
Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization
Martha Aguirre
Fertility and Sterility, 2005
View PDFchevron_right